Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients

Annals of the Rheumatic Diseases

Volumn 73, Issue 1, 2014, Pages 227-232

  Aggarwal, Rohit ^a   Cassidy, Elaine ^a   Fertig, Noreen ^a   Koontz, Diane Carol ^a   Lucas, Mary ^a   Ascherman, Dana P ^b   Oddis, Chester V ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; JO 1 ANTIBODY; TRNA SYNTHETASE AUTOANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; CAUSE OF DEATH; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DELAYED DIAGNOSIS; ETHNICITY; EVENT FREE SURVIVAL; FEMALE; GENDER; HUMAN; LUNG FIBROSIS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MYOSITIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURVIVAL FACTOR; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC SCLEROSIS;

AUTOANTIBODIES; DERMATOMYOSITIS; OUTCOMES RESEARCH; POLYMYOSITIS;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; CONNECTIVE TISSUE DISEASES; FEMALE; HISTIDINE-TRNA LIGASE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SEROEPIDEMIOLOGIC STUDIES;

EID: 84889649311     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-201800     Document Type: Article

References (30)

1. Hirakata M. Autoantibodies to aminoacyl-tRNA synthetases. Intern Med 2005;44:527-8. (Pubitemid 40932819)
2. Mammen AL. Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis. Ann N Y Acad Sci 2010;1184:134-53.
3. Targoff IN. Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol 2000;12:475-81.
4. Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991;70:360-74.
5. Yamasaki Y, Yamada H, Nozaki T, et al. Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis. Arthritis Rheum 2006;54:2004-9. (Pubitemid 43877951)
6. Sato S, Kuwana M, Hirakata M. Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies. Rheumatology (Oxford) 2007;46:842-5. (Pubitemid 47061719)
7. Hirakata M, Suwa A, Nagai S, et al. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol 1999;162:2315-20. (Pubitemid 29288856)
8. Hirakata M, Suwa A, Takada T, et al. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum 2007;56:1295-303. (Pubitemid 46608655)
9. Kalluri M, Sahn SA, Oddis CV, et al. Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature. Chest 2009;135:1550-6.
10. Yoshifuji H, Fujii T, Kobayashi S, et al. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 2006;39:233-41. (Pubitemid 43879036)
11. Fischer A, Swigris JJ, du Bois RM, et al. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir Med 2009;103:1719-24.
12. Ghirardello A, Zampieri S, Tarricone E, et al. Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity 2006;39:217-21. (Pubitemid 43879034)
13. Allan PF, Kehoe K, Abouchahine S, et al. Pulmonary manifestations of polymyositis/ dermatomyositis. Clin Pulm Med 2006;13:37-52.
14. Danko K, Ponyi A, Constantin T, et al. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine (Baltimore) 2004;83:35-42. (Pubitemid 38124854)
15. Marie I, Hachulla E, Cherin P, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002;47:614-22. (Pubitemid 35461314)
16. Grau JM, Miro O, Pedrol E, et al. Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement. J Rheumatol 1996;23:1921-6. (Pubitemid 26376117)
17. Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis- dermatomyositisassociated interstitial lung disease. Am J Respir Crit Care Med 2001;164:1182-5.
18. Kang EH, Lee EB, Shin KC, et al. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology (Oxford) 2005;44:1282-6. (Pubitemid 41487962)
19. Selva-O'Callaghan A, Labrador-Horrillo M, Munoz-Gall X, et al. Polymyositis/ dermatomyositis-associated lung disease: analysis of a series of 81 patients. Lupus 2005;14:534-42. (Pubitemid 41161085)
20. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
21. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
22. Okano Y, Steen VD, Medsger TA Jr. Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum 1992;35:95-100.
23. Mitri GM, Lucas M, Fertig N, et al. A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum 2003;48:203-9. (Pubitemid 36091664)
24. Sultan SM, Ioannou Y, Moss K, et al. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford) 2002;41:22-6. (Pubitemid 34537916)
25. Torres C, Belmonte R, Carmona L, et al. Survival, mortality and causes of death in inflammatory myopathies. Autoimmunity 2006;39:205-15. (Pubitemid 43879033)
26. Chen YJ, Wu CY, Shen JL. Predicting factors of interstitial lung disease in dermatomyositis and polymyositis. Acta Derm Venereol 2007;87:33-8.
27. Chatterjee S, Farver C. Severe pulmonary hypertension in Anti-Jo-1 syndrome. Arthritis Care Res 2010;62:425-9.
28. Richards TJ, Eggebeen A, Gibson K, et al. Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. Arthritis Rheum 2009;60:2183-92.
29. Aggarwal R, Lucas M, Fertig N, et al. Anti-U3 RNP autoantibodies in systemic sclerosis. Arthritis Rheum 2009;60:1112-18.
30. Sato S, Hirakata M, Kuwana M, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 2005;52:1571-6. (Pubitemid 40663949)